Stay updated on NasoVAX in Early COVID-19 Clinical Trial
Sign up to get notified when there's something new on the NasoVAX in Early COVID-19 Clinical Trial page.

Latest updates to the NasoVAX in Early COVID-19 Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedThe per-state 'X Locations' headers have been replaced with a consolidated 'Locations' section listing Florida, Georgia, Illinois, North Carolina, and Texas. This update, part of revision v3.3.3, changes the layout and presentation of site locations.SummaryDifference0.7%

- Check20 days agoNo Change Detected
- Check27 days agoNo Change Detected
- Check34 days agoChange DetectedThe update consists of a site revision note (Revision: v3.3.2) replacing the previous v3.3.1; no changes to core study content or navigation evident. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check41 days agoChange DetectedPage shows Revision: v3.3.1 replacing v3.2.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check49 days agoChange DetectedRemoved the government funding lapse notice that previously cautioned users about potential delays in updates; the study details remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check63 days agoChange DetectedThe page now shows Terminated Enrollment for NCT04442230, with the study status updated and enrollment closed.SummaryDifference0.5%

- Check92 days agoChange DetectedAdded a prominent operating-status notice and version bump to v3.2.0; removed the previous v3.1.0 version reference.SummaryDifference4%

Stay in the know with updates to NasoVAX in Early COVID-19 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the NasoVAX in Early COVID-19 Clinical Trial page.